Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley J Goldsmith

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphomaJohn P Leonard, Morton Coleman, Lale Kostakoglu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 25, 2014
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancerShankar Vallabhajosula, Anastasia Nikolopoulou, John W Babich, et al.
Pancreas|July 29, 2010
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasMatthew H Kulke, Lowell B Anthony, David L Bushnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancerScott T Tagawa, Matthew I Milowsky, Michael Morris, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2013
First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancerJohn A Barrett, R Edward Coleman, Stanley J Goldsmith, et al.
Neurobiology of Aging|April 17, 2012
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parentsLisa Mosconi, Juha O Rinne, Wai H Tsui, et al.
The Journal of Clinical Investigation|July 11, 2006
Possible axonal regrowth in late recovery from the minimally conscious stateHenning U Voss, Aziz M Uluğ, Jonathan P Dyke, et al.
Health Physics|March 27, 2015
Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960-2010Vladimir Drozdovitch, Aaron B Brill, Ronald J Callahan, et al.
Health Physics|August 28, 2014
Nuclear medicine practices in the 1950s through the mid-1970s and occupational radiation doses to technologists from diagnostic radioisotope proceduresVladimir Drozdovitch, Aaron B Brill, Fred A Mettler, et al.
Cancer|May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trialAllyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphomaJohn P Leonard, Morton Coleman, Lale Kostakoglu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 25, 2014
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancerShankar Vallabhajosula, Anastasia Nikolopoulou, John W Babich, et al.
Pancreas|July 29, 2010
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasMatthew H Kulke, Lowell B Anthony, David L Bushnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancerScott T Tagawa, Matthew I Milowsky, Michael Morris, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2013
First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancerJohn A Barrett, R Edward Coleman, Stanley J Goldsmith, et al.
Neurobiology of Aging|April 17, 2012
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parentsLisa Mosconi, Juha O Rinne, Wai H Tsui, et al.
The Journal of Clinical Investigation|July 11, 2006
Possible axonal regrowth in late recovery from the minimally conscious stateHenning U Voss, Aziz M Uluğ, Jonathan P Dyke, et al.
Health Physics|March 27, 2015
Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960-2010Vladimir Drozdovitch, Aaron B Brill, Ronald J Callahan, et al.
Health Physics|August 28, 2014
Nuclear medicine practices in the 1950s through the mid-1970s and occupational radiation doses to technologists from diagnostic radioisotope proceduresVladimir Drozdovitch, Aaron B Brill, Fred A Mettler, et al.
Cancer|May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trialAllyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.
Pageof 7